1. Home
  2. Products
  3. t:slim X2 Insulin Pump
Tandem_HCP_Insulin_Pump_tslimX2_Non-CGM

 

A pump that is simple to use, simple to learn, and simple to teach.

Diabetes care is a complex and ongoing collaboration between you, your patients, and sometimes a caregiver, which is why we designed the t:slim X2™ insulin pump to be simple to use, simple to learn, and simple to teach.

The t:slim X2 pump offers your patients simple-to-learn technology they expect in a modern device.

Zero Fingersticks

When the t:slim X2 pump is integrated with Dexcom G6 CGM, zero fingersticks are required for calibration or mealtime dosing.†

Remote Software Updates, a Tandem Exclusive

Tandem Diabetes Care is the only company that lets pump users remotely update their insulin pump software using the Tandem Device Updater.‡

The Smallest Pump Available

Watertight and rechargeable via a micro-USB port, the t:slim X2 pump is also the smallest pump on the market—up to 38% smaller.1

Easy Reporting

Use our t:connect® web application to access patient pump data, print reports to share with patients and caregivers, and fine tune treatment approaches.

A Free Virtual Pump Demo

Open our t:simulator™ app, and experience the t:slim X2 insulin pump’s simple touchscreen interface on your mobile device.

Versatile Enough for Most Patients

The t:slim X2 pump can be used with or without advanced features like CGM integration and automated insulin delivery algorithms.

 
 
† Zero fingersticks required when using the t:slim X2 pump with Dexcom G6 CGM integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Request to be Contacted

If you are a clinician and want to learn more about our products, please fill out this form and a representative will contact you. If you are a Tandem pump user, please contact Tandem.

All form fields are required. By submitting this form, you grant Tandem Diabetes Care, Inc. permission to add your contact information to our database to send you information and communications related to our products. We respect and uphold the confidentiality of your personal information, and will not share your information with any third parties, except as noted in our privacy policy. A link to our privacy policy is available at the bottom of this page.

Responsible Use of Control-IQ Technology

Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, patients are still responsible for actively managing their diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires that patients accurately input information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless all system components, including CGM, infusion sets and pump cartridges, are used as instructed. Importantly, the system cannot adjust insulin dosing if the pump is not receiving CGM readings. Since there are situations and emergencies that the system may not be capable of identifying or addressing, patients should always pay attention to their symptoms and treat accordingly.

Responsible Use of Basal-IQ Technology

Systems like the t:slim X2 insulin pump with Basal-IQ technology are not substitutes for the active management of diabetes. There are common scenarios in which automated systems cannot prevent a hypoglycemic event. The Basal-IQ feature relies on current CGM sensor readings to function and will not be able to predict glucose levels and suspend insulin delivery if a patient’s CGM is not functioning properly or his/her pump is unable to receive the CGM signal. It’s recommended your patient always uses the components of the pump system (pump, cartridges, CGM, and infusion sets) according to the applicable instructions for use and checks them regularly to make sure they are functioning as expected. Patients should always pay attention to their symptoms, actively monitor and manage glucose levels, and treat according to your recommendations.

* CGM sold separately.
† Zero fingersticks required when using the t:slim X2 pump with Dexcom G6 Continuous Glucose Monitoring (CGM) integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
‡ Additional feature updates are not currently available for the t:slim X2 pump with Basal-IQ or Control-IQ technology and are subject to future FDA approvals. A prescription and additional training may be required to access certain future software updates. Charges may apply.

Reference:
1. 38% smaller than the Medtronic MiniMed 630G and 670G and at least 28% smaller than the MiniMed 530G, Animas Vibe, and Omnipod system. Data on file with Tandem Diabetes Care.

Important Safety Information

RX ONLY. The t:slim X2 insulin pump, Basal-IQ technology, and Control-IQ technology are intended for single patient use. The t:slim X2 pump, Basal-IQ technology, and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin.

t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in individuals six years of age and greater. Basal-IQ technology:Basal-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically suspend delivery of insulin based on iCGM readings and predicted glucose values. The bolus calculator is indicated for the management of diabetes by people with diabetes by calculating an insulin dose or carbohydrate intake based on user entered data. Basal-IQ technology is intended for the management of diabetes mellitus in persons six years of age and greater. Control-IQ technology:Control-IQ technology is intended for use with a compatible iCGM (sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

 
Control-IQ technology and Basal-IQ technology are not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump, Basal-IQ technology, and Control-IQ technology must: be able and willing to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. visit www.tandemdiabetes.com/safetyinfo for additional important safety information.